<DOC>
	<DOCNO>NCT00001917</DOCNO>
	<brief_summary>The purpose study use brain image technology study effect age Alzheimer 's Disease ( AD ) specific type brain receptor . The brain make cell call neuron . The neuron communicate one another secrete chemical call neurotransmitter . The neurotransmitter bind specific site neuron call receptor . Acetylcholine ( ACh ) neurotransmitter bind ACh receptor . In age AD , number neuron secrete ACh decrease function ACh receptor change . This study use positron emission tomography ( PET ) scan brain study effect age AD muscarinic type 2 [ M2 ] , type ACh receptor . Participants study injected radioactive tracer ( ligand [ F-18 ] FP-TZTP ) bind [ M2 ] receptor . Participants undergo PET scan order density function [ M2 ] receptor study .</brief_summary>
	<brief_title>Brain Imaging Elderly People Individuals With Alzheimer 's Disease</brief_title>
	<detailed_description>The Geriatric Psychiatry Branch ( GPB ) National Institute Mental Health ( NIMH ) propose study effect age Alzheimer 's Disease ( AD ) muscarinic type 2 ( M2 ) receptor density function use ligand [ F-18 ] FP-TZTP . M2 receptor primarily autoreceptors find acetylcholine ( ACh ) neuron , lose along ACh neuron age AD , particularly cerebral cortex . As near completion study young versus old , would like add healthy subject achieve good gender balance , continue accrual Alzheimer 's patient expand Protocol include natural scientific progression . Quantification M2 receptor single FP-TZTP scan currently perform 99-M-0073 provide measure number cholinergic receptor brain , capacity release acetylcholine synapse . To test capacity require second TZTP scan use agent alters acetylcholine concentration synapse . Non-human primate study perform ( 1 ) find PET scan FP-TZTP sensitive change acetylcholine synapse concentration , result competition , response adminstration acetylinesterase inhibitor physostigmine . We would like use physostigmine group ; young , old normal , Alzheimer 's patient infer difference capacity release acetylcholine .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>INCLUSION CRITERIA : Healthy male females 20100 year old volunteer AD . AD volunteer must meet NINCDSADRDA criterion possible , probable , definite AD . All subject require prescription medication could effect PET scan , medication anticholinergic effect , two week one month prior PET scan , psychotropic medication one month . Subjects caution consume alcohol , marijuana , psychotropic drug study , smoke , use caffeinated beverage , take overthecounter medication cold medication ( ie : Benadryl , Sudafed ) least 12 hour prior PET scan . EXCLUSION CRITERIA : Patients withe significant cardiovascular disease , history alcoholism , significant head trauma , uncontrolled hypertension , diabetes , bleed disorder medical condition would make medically unsafe perform part PET scan would confound data analysis . Subjects evidence significant chronic disease accept healthy control group . Subjects must pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Physostigmine</keyword>
	<keyword>Visual Stimulation</keyword>
	<keyword>Cholinergic Stimulation</keyword>
	<keyword>[ F-18 ] FP-TZIP</keyword>
	<keyword>Aging</keyword>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Visual Activation</keyword>
</DOC>